Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for receptors.
Fig. 1. The sreening workflow of Receptor.AI
The method involves detailed molecular simulations of the receptor in its native membrane environment, with ensemble virtual screening focusing on its conformational mobility. When dealing with dimeric or oligomeric receptors, the whole functional complex is modelled, and the tentative binding pockets on and between the subunits are established to address all possible mechanisms of action.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
P41180
UPID:
CASR_HUMAN
Alternative names:
Parathyroid cell calcium-sensing receptor 1
Alternative UPACC:
P41180; Q13912; Q16108; Q16109; Q16110; Q16379; Q2M1T0; Q4PJ19
Background:
The Extracellular calcium-sensing receptor, also known as Parathyroid cell calcium-sensing receptor 1, is pivotal in maintaining calcium homeostasis. It detects extracellular calcium ion concentrations, influencing parathyroid hormone production. This receptor's activity involves a G-protein that activates a phosphatidylinositol-calcium second messenger system, with activation requiring both aromatic amino acids and divalent cations.
Therapeutic significance:
Linked to diseases such as Hypocalciuric hypercalcemia, familial 1, and Neonatal severe hyperparathyroidism, this receptor's understanding could lead to novel treatments for calcium homeostasis disorders. Its role in Hypocalcemia, autosomal dominant 1, and Epilepsy, idiopathic generalized 8, further underscores its potential in therapeutic strategies.